Artificial Intelligence AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials by admin April 24, 2026 Views: 2 This post was originally published on this site Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.” Post navigation Previous PostCrypto PAC Fellowship halts support of Texas AG for Senate: Report Next PostCrypto Biz: Same players, bigger bets as crypto eyes a rebound
